Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort studyErica A. Voss, Rohit Vashisht, Daniel J. Dedman et al.|EClinicalMedicine|2023Cited by 27
Comparing the Neuroprotective Effects of Telmisartan, Perindopril, and Nebivolol Against Lipopolysaccharide-Induced Injury in Neuron-Like CellsSelçuk Şen, Ebru Hacıosmanoğlu|Cureus|2022Cited by 8